-+ 0.00%
-+ 0.00%
-+ 0.00%

Seres Therapeutics Q3 EPS $0.94 Beats $0.67 Estimate, Sales $351.000K Miss $5.875M Estimate

Benzinga·11/05/2025 12:04:19
Listen to the news
Seres Therapeutics (NASDAQ:MCRB) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.67 by 40.3 percent. This is a 114.24 percent increase over losses of $(6.60) per share from the same period last year. The company reported quarterly sales of $351.000 thousand which missed the analyst consensus estimate of $5.875 million by 94.03 percent.